Phase 2
N=1,721
Trial of Activity for Adolescent Girls (TAAG)
Cardiovascular Diseases · Heart Diseases · Obesity
Bottom Line
View on ClinicalTrials.gov: NCT00006409 ↗Enrolled (actual)
1,721
Serious AEs
0.0%
Results posted
May 2010
Primary outcome: Primary: MET-weighted MVPA: Daily Minutes of Moderate-to-vigorous Physical Activity (MVPA) Weighted by Metabolic Equivalent of Task (MET) — 136.5; 136.9 Minutes of MET-weighted MVPA˙
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 2
- Interventions
- Trial of Activity for Adolescent Girls (TAAG) (Behavioral)
- Age
- Pediatric · 12+ yrs
- Sex
- Female
- Sponsor
- University of North Carolina, Chapel Hill
- Primary completion
- Aug 2008
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY MET-weighted MVPA: Daily Minutes of Moderate-to-vigorous Physical Activity (MVPA) Weighted by Metabolic Equivalent of Task (MET) |
136.4; 125.5 | — |
| PRIMARY MET-weighted MVPA: Daily Minutes of Moderate-to-vigorous Physical Activity (MVPA) Weighted by Metabolic Equivalent of Task (MET) |
136.4; 125.5 | — |
Summary
To test the effectiveness of a multicomponent school-based and community-linked intervention in preventing the decline in physical activity levels and cardiovascular fitness in girls in grades 6-8.
Eligibility Criteria
School inclusion criteria:
- Public middle schools in which a majority of students lived in the surrounding community
- Enrollment of at least 90 8th-grade girls
- Yearly withdrawal rates less than 28%
- At least one semester of physical education required for each grade
- Willingness to sign a memorandum of understanding and accept random assignment of the school
Student exclusion criteria:
- Limited English-speaking skills
- Unable to participate in physical education classes due to a medical condition or disability
- Contraindications for participating in a submaximal exercise test
Data sourced from ClinicalTrials.gov (NCT00006409). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.